Insider Transactions in Q1 2021 at Sensei Biotherapeutics, Inc. (SNSE)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,000
+0.04%
|
$24,000
$12.0 P/Share
|
|
Mar 30
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$24,000
$12.0 P/Share
|
|
Mar 24
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
3,750
+0.08%
|
$52,500
$14.12 P/Share
|
|
Mar 24
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
3,750
+0.08%
|
$52,500
$14.12 P/Share
|
|
Mar 23
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
10,000
+0.21%
|
$140,000
$14.34 P/Share
|
|
Mar 23
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.21%
|
$140,000
$14.34 P/Share
|
|
Mar 22
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,183
+0.05%
|
$32,745
$15.02 P/Share
|
|
Mar 22
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,183
+0.05%
|
$32,745
$15.02 P/Share
|
|
Mar 18
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
817
+0.02%
|
$12,255
$15.25 P/Share
|
|
Mar 18
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
817
+0.02%
|
$12,255
$15.25 P/Share
|
|
Mar 08
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$15,000
$15.25 P/Share
|
|
Mar 08
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.02%
|
$15,000
$15.25 P/Share
|
|
Mar 05
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
8,000
+0.17%
|
$104,000
$13.75 P/Share
|
|
Mar 05
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
8,000
+0.17%
|
$104,000
$13.75 P/Share
|
|
Mar 04
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
2,000
+0.04%
|
$28,000
$14.12 P/Share
|
|
Mar 04
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$28,000
$14.12 P/Share
|
|
Mar 03
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
3,000
+0.06%
|
$45,000
$15.85 P/Share
|
|
Mar 03
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
3,000
+0.06%
|
$45,000
$15.85 P/Share
|
|
Mar 02
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
3,000
+0.06%
|
$48,000
$16.25 P/Share
|
|
Mar 02
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
3,000
+0.06%
|
$48,000
$16.25 P/Share
|
|
Feb 26
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
5,000
+0.1%
|
$80,000
$16.25 P/Share
|
|
Feb 26
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.1%
|
$80,000
$16.25 P/Share
|
|
Feb 25
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
12,000
+0.25%
|
$180,000
$15.79 P/Share
|
|
Feb 25
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
12,000
+0.25%
|
$180,000
$15.79 P/Share
|
|
Feb 24
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
19,000
+0.2%
|
$323,000
$17.63 P/Share
|
|
Feb 24
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
19,000
+0.2%
|
$323,000
$17.63 P/Share
|
|
Feb 23
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
20,300
+0.21%
|
$345,100
$17.57 P/Share
|
|
Feb 23
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
20,300
+0.21%
|
$345,100
$17.57 P/Share
|
|
Feb 22
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
9,802
+0.21%
|
$176,436
$18.88 P/Share
|
|
Feb 22
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
9,802
+0.21%
|
$176,436
$18.88 P/Share
|
|
Feb 19
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
11,786
+0.25%
|
$223,934
$19.77 P/Share
|
|
Feb 19
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
11,786
+0.25%
|
$223,934
$19.77 P/Share
|
|
Feb 18
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
753
+0.02%
|
$14,307
$19.75 P/Share
|
|
Feb 18
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
753
+0.02%
|
$14,307
$19.75 P/Share
|
|
Feb 08
2021
|
Cambrian Bio Pharma Inc |
BUY
Conversion of derivative security
|
Direct |
2,407,328
+33.92%
|
-
|
|
Feb 08
2021
|
H&S Investments I LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,361,835
+49.63%
|
-
|
|
Feb 08
2021
|
James Peyer |
BUY
Conversion of derivative security
|
Indirect |
2,407,328
+33.92%
|
-
|
|
Feb 08
2021
|
Thomas G Ricks |
BUY
Conversion of derivative security
|
Indirect |
301,769
+50.0%
|
-
|